Harry Kovelman - 13 Oct 2026 Form 4 Insider Report for MYOMO, INC. (MYO)

Reporting relationship: Chief Medical Officer
Issuer ticker: MYO
Reported as of: 13 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Oct 2026, 16:30:25 UTC
Prior SEC filing: 15 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ David A. Henry, Attorney-in-Fact

Key filing fact

Harry Kovelman filed Form 4 for MYOMO, INC. (MYO) on 15 Oct 2026.

Key facts

This page summarizes Harry Kovelman's Form 4 filing for MYOMO, INC. (MYO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Oct 2026, 16:30.

Change

Previous filing in this sequence was filed on 15 Oct 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001853204 Primary reporting owner

Kovelman Harry

Relationship: Chief Medical Officer
Address: C/O MYOMO, INC., 45 BLUE SKY DR., SUITE 101, BURLINGTON
Signature: /s/ David A. Henry, Attorney-in-Fact
Signature date: 15 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYO transaction

Common Stock

Award

Transaction value
Shares: +32,500
Change %: +36%
Price: $0.000000^*
Shares after: 122,389
Date: 13 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents grant of restricted stock units ("RSUs") under the Company's 2018 Stock Option and Incentive Plan. The RSUs vest in three equal annual installments beginning on June 9, 2027.